Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
- 6 May 2003
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (3) , S52-S57
- https://doi.org/10.1016/s0041-1345(03)00244-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1Transplantation, 2002
- CHARACTERISTICS OF SIROLIMUS-ASSOCIATED INTERSTITIAL PNEUMONITIS IN RENAL TRANSPLANT PATIENTSTransplantation, 2001
- SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10Transplantation, 2001
- BRONCHIOLITIS OBLITERANS AND ORGANIZING PNEUMONIA IN RENAL TRANSPLANT RECIPIENTSTransplantation, 2000
- SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12Transplantation, 2000
- Clinical pharmacokinetics and therapeutic drug monitoring of sirolimusClinical Therapeutics, 2000
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapyKidney International, 1996
- Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of ActionTherapeutic Drug Monitoring, 1995